On August 5, the strategic signing ceremony between Wuhan Ammunition Life Technology Co., Ltd. and the internationally renowned company Roche Diagnostics was successfully held in Wuhan.

GRAIL, LLC, a healthcare company whose mission is to detect cancer early when it can be cured, today announced a broad strategic collaboration with AstraZeneca (LSE/STO/Nasdaq: AZN) to develop and commercialize companion diagnostic (CDx) assays for use with AstraZeneca’s therapies.

Recently, Shenzhen Third People's Hospital/The Second Affiliated Hospital of Southern University of Science and Technology and Roche Diagnostics formally reached a strategic cooperation to jointly establish the "Roche Strategic Cooperation Hospital".

NEW YORK – Qiagen said on Thursday that it has formed a global strategic alliance with Japan's Sysmex to develop and commercialize cancer companion diagnostics using Sysmex's Plasma-Safe-SeqS next-generation sequencing technology.